Show simple item record

dc.contributor.authorChaliha, Devahuti Rai
dc.contributor.supervisorJohn Mamoen_US
dc.contributor.supervisorMauro Vaccarezzaen_US
dc.contributor.supervisorVirginie Lamen_US
dc.date.accessioned2025-02-14T06:30:34Z
dc.date.available2025-02-14T06:30:34Z
dc.date.issued2024en_US
dc.identifier.urihttp://hdl.handle.net/20.500.11937/97135
dc.description.abstract

While studies imply it is cerebral vasodilation that triggers migraine pain onset, we suggest the carbon-dioxide-inducing vasodilation rescues migraine phenotype by restoring central capillary perfusion instead. We conducted a 12-week, phase-II, single-site, randomised, double-blind, parallel-group, placebo-controlled trial in male and female adults with chronic frequent episodic migraines (4 treatment arms: placebo, L-arginine, aged garlic extract (AGE), and L-arginine + 1 g AGE). The descending order of efficacy was as follows: L-arginine, then AGE, then combination.

en_US
dc.publisherCurtin Universityen_US
dc.titleInvestigating the Efficacy of L-Arginine and Aged Garlic Extract in a Randomised Place-Controlled Clinical Trial: A Vasodilatory Nutraceutical Strategy for Migraine Preventionen_US
dc.typeThesisen_US
dcterms.educationLevelPhDen_US
curtin.departmentSchool of Population Healthen_US
curtin.accessStatusOpen accessen_US
curtin.facultyHealth Sciencesen_US
curtin.contributor.orcidChaliha, Devahuti Rai [0000-0002-7376-0209]en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record